comparemela.com

Latest Breaking News On - Julia vergin - Page 3 : comparemela.com

AstraZeneca: What′s the deal with thrombosis? | Science| In-depth reporting on science and technology | DW

German EU lawmaker Katarina Barley on vaccine dilemmas However, this type of thrombosis is considered rather rare, looking at its incidence: It is estimated that two to five people per 1 million experience CVST over the course of a year. However, recent studies indicate a higher number of people affected. As many as 15.7 cases per million people per year have been reported in an Australian study, says Paul Hunter, professor of medicine at the University of East Anglia. That would mean the current incidence is underestimated by four to eight times, according to Hunter. Does thrombosis always equal thrombosis? Since the announcement of the vaccination suspension, there has been much discussion.  Especially on social media, there were many angry responses: Why is the contraception pill still prescribed, even though it is known that roughly 1,100 women will suffer thrombosis among every 1 million who take it. In comparison: Why do authorities throw the entire vaccination strategy

Opinion: Do not write off the AstraZeneca vaccine | Science| In-depth reporting on science and technology | DW

The dangers of thrombosis High risk of thrombosis in everyday life All of this is no reason to panic: We deliberately take on much higher thrombosis risks elsewhere than they might now perhaps come by the way of vaccination. In a well-known and scientifically proved example, for every million women who take the birth control pill, about 1,100 will get thrombosis. In addition, various circumstances or behaviors  have been shown to double our risk of thrombosis. These include: obesity, travel (especially long-distance flights, car, bus or train rides) and  smoking.  All of these factors have been clearly proved scientifically. A possible link to vaccinations has not been proved at all.

COVID: Sanofi starts human trials of 2nd vaccine candidate | News | DW

COVID-19 vaccination: Voices from around the world Participants will receive either a single dose of the vaccine or two doses 21 days apart. Three dose levels will be examined, the companies said. When could the vaccine get approval? In December 2020, Sanofi had said it was eyeing earliest potential approval of its mRNA vaccine in the second half of 2021, following positive preclinical data. Researchers and their self-experiments An oral vaccination against coronavirus Courage, curiosity or complete hubris? It s probably a mixture of all these things that causes many scientists to test their own inventions on themselves first. According to the Global Times, a Chinese doctor not only developed an oral vaccine against the SARS-CoV-2 but also tried it out himself. So far, he hasn t seen any side effects.

COVID infections in children ― what do we know?

COVID infections in children ― what do we know? Julia Vergin © Provided by dw.com Schools in Germany have partially reopened, but experts are concerned about the COVID risk for children The number of cases among the under-15-year-olds is rising sharply, Lothar Wieler, president of the Robert-Koch-Institute, Germany s disease control and prevention agency, said in a press conference with Health Minister Jens Spahn on Friday. There are signs that the B.1.1.7 variant first discovered in the UK is a driving factor behind the growing number of outbreaks in kindergartens, Wiehler added. The news comes just as schools and kindergartens are starting to either fully or partially reopen in Germany ― which is why Johannes Liese, head of pediatric infectiology and immunology at university hospital Würzburg, says he isn t exactly surprised by the rise in cases.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.